Abstract
Because of the success of various treatment approaches in most clinical settings of Hodgkin's disease (HD), it is now both possible and necessary to consider late effects and cost in the selection of a treatment plan for a given patient. Staging and therapeutic strategies are inextricably linked, with some treatment approaches requiring more staging information than others. As we evaluate the therapeutic options available, it is also appropriate to examine the roles of both standard and newly developed diagnostic procedures used in HD to determine their value and cost in the overall management approach. This article defines the role of staging in various treatment approaches, reviews the results achieved with available diagnostic procedures, and offers staging guidelines for various clinical settings.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
